SCHEMBL31448477

SCHEMBL31448477

CNc1c(Br)cccc1Cc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.44
IDO1 P14902 2/20 0.38
PNMT P11086 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CHRM2 P08172 1/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
AOC3 Q16853 1/20 0.35
EGFR P00533 1/20 0.34
FLT1 P17948 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31448458 0.82 SLC6A2 (0.38) GABRA1GABRB2SLC6A2SLC6A4SLC6A3
SCHEMBL31448553 0.78 SMN1; SMN2 (0.43) TAAR1IDO1PNMTLMNASMN1; SMN2
SCHEMBL30772397 0.76 HTT (0.42) TAAR1IDO1PNMTSMN1; SMN2SLC6A2
SCHEMBL25430225 0.74 TAAR1 (0.41) TAAR1IDO1GABRA1GABRB2SLC6A2
SCHEMBL29519238 0.74 IDO1 (0.62) TAAR1IDO1PNMTLMNANPC1
SCHEMBL672407 0.74 IDO1 (0.62) TAAR1IDO1PNMTLMNANPC1
SCHEMBL29766550 0.74 TAAR1 (0.41) TAAR1IDO1GABRA1GABRB2SLC6A2
SCHEMBL31448502 0.72 POLB (0.36) LMNASMN1; SMN2NPC1RAB9A
SCHEMBL20892638 0.72 ALDH1A1 (0.39) TAAR1GABRA1GABRB2
SCHEMBL31448554 0.70 SLC6A4 (0.35) TAAR1SMN1; SMN2GABRA1GABRB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2025-11-27 US disclosed
EP-4512801-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND Kissei Pharmaceutical Co., Ltd. (JP) 2025-02-26 EP disclosed
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND TSHR, TRHR, GHSR TAAR1 390/4885IDO1 1815/4885PNMT 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.